Literature DB >> 16110817

Invasive aspergillosis in primary immunodeficiencies.

N G Almyroudis1, S M Holland, B H Segal.   

Abstract

Primary immunodeficiencies are rare and usually first manifest during childhood. Invasive aspergillosis is the leading cause of mortality in chronic granulomatous disease (CGD), reflecting the key role of the phagocyte NADPH oxidase in host defense against opportunistic fungi. Despite interferon-gamma prophylaxis, invasive filamentous fungal infections are a persistent problem in CGD. Key principles of management of fungal infections involve early recognition and aggressive treatment and appropriate surgical debridement of localized disease. Because CGD is a disorder of phagocyte stem cells in which the gene defects are well defined, it is a model disease to evaluate immune reconstitution through stem cell transplantation and gene therapy. Patients with the hyper-IgE syndrome with recurrent infections (Job syndrome) are prone to colonization of lung cavities (pneumatoceles) by Aspergillus species leading to local invasion and rarely disseminated infection. Other primary phagocytic disorders, T-cell disorders, and mitochondrial disorders are uncommonly associated with invasive aspergillosis. Taken together, these rare primary immunodeficiencies highlight the complex coordination of both innate and acquired pathways mediating host defense against Aspergillus infection.

Entities:  

Mesh:

Year:  2005        PMID: 16110817     DOI: 10.1080/13693780400025203

Source DB:  PubMed          Journal:  Med Mycol        ISSN: 1369-3786            Impact factor:   4.076


  26 in total

1.  Invasive aspergillosis in chronic granulomatous disease: report of 7 cases.

Authors:  Setareh Mamishi; Nima Parvaneh; Ali Salavati; Sina Abdollahzadeh; Mehdi Yeganeh
Journal:  Eur J Pediatr       Date:  2006-06-28       Impact factor: 3.183

2.  Effect of amphotericin B and micafungin combination on survival, histopathology, and fungal burden in experimental aspergillosis in the p47phox-/- mouse model of chronic granulomatous disease.

Authors:  Carly G Dennis; William R Greco; Yseult Brun; Richard Youn; Harry K Slocum; Ralph J Bernacki; Russell Lewis; Nathan Wiederhold; Steven M Holland; Ruta Petraitiene; Thomas J Walsh; Brahm H Segal
Journal:  Antimicrob Agents Chemother       Date:  2006-02       Impact factor: 5.191

Review 3.  Immunity to microbes: lessons from primary immunodeficiencies.

Authors:  Magda Carneiro-Sampaio; Antonio Coutinho
Journal:  Infect Immun       Date:  2007-02-05       Impact factor: 3.441

4.  Expression of immunomodulatory genes in human monocytes induced by voriconazole in the presence of Aspergillus fumigatus.

Authors:  M Simitsopoulou; E Roilides; C Likartsis; J Ioannidis; A Orfanou; F Paliogianni; T J Walsh
Journal:  Antimicrob Agents Chemother       Date:  2006-12-18       Impact factor: 5.191

Review 5.  Bacillus Calmette-Guérin (BCG) complications associated with primary immunodeficiency diseases.

Authors:  Sayna Norouzi; Asghar Aghamohammadi; Setareh Mamishi; Sergio D Rosenzweig; Nima Rezaei
Journal:  J Infect       Date:  2012-03-16       Impact factor: 6.072

6.  Hemoptysis in a Patient with Elevated Immunoglobulin E.

Authors:  Yael Gernez; Angela Tsuang; Tukisa D Smith; Khurram Shahjehan; Yiqun Hui; Paul J Maglione; Charlotte Cunningham-Rundles
Journal:  J Allergy Clin Immunol Pract       Date:  2016-09-29

7.  Aspergillus fumigatus stimulates the NLRP3 inflammasome through a pathway requiring ROS production and the Syk tyrosine kinase.

Authors:  Najwane Saïd-Sadier; Eduardo Padilla; Gordon Langsley; David M Ojcius
Journal:  PLoS One       Date:  2010-04-02       Impact factor: 3.240

8.  Galactomannan antigenemia in pediatric oncology patients with invasive aspergillosis.

Authors:  Randall Hayden; Stanley Pounds; Katherine Knapp; Ruta Petraitiene; Robert L Schaufele; Tin Sein; Thomas J Walsh
Journal:  Pediatr Infect Dis J       Date:  2008-09       Impact factor: 2.129

9.  Immunomodulatory effects of voriconazole on monocytes challenged with Aspergillus fumigatus: differential role of Toll-like receptors.

Authors:  Maria Simitsopoulou; Emmanuel Roilides; Fotini Paliogianni; Christodoulos Likartsis; John Ioannidis; Kalliopi Kanellou; Thomas J Walsh
Journal:  Antimicrob Agents Chemother       Date:  2008-07-14       Impact factor: 5.191

10.  Treosulfan-based conditioning regimen in a second matched unrelated peripheral blood stem cell transplantation for a pediatric patient with CGD and invasive aspergillosis, who experienced initial graft failure after RIC.

Authors:  Maja Agnieszka Klaudel-Dreszler; Krzysztof Kalwak; Magdalena Kurenko-Deptuch; Beata Wolska-Kusnierz; Edyta Heropolitanska-Pliszka; Barbara Pietrucha; Bożena Mikoluc; Ewa Gorczyńska; Marek Ussowicz; Alicja Chybicka; Ewa Bernatowska
Journal:  Int J Hematol       Date:  2009-10-29       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.